e.g. mhealth
Search Results (1 to 10 of 10 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 5 JMIR Research Protocols
- 2 JMIR Public Health and Surveillance
- 2 Journal of Medical Internet Research
- 1 JMIR Formative Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)

Recently, the literature has advocated antimicrobial stewardship programs to reduce inappropriate antibiotic prescriptions and improve adherence to medical guidelines in primary care [3]. Several levers have been proposed to change behavior: active or passive training [4], audits and clinical practice feedback [5], patient-focused actions, nudge interventions [6], and financial incentives [7].
J Med Internet Res 2024;26:e60535
Download Citation: END BibTex RIS

Antimicrobial resistance (AMR) is among the greatest threats to global health and is predicted to become the leading cause of death by 2050 [1,2]. Mortality due to AMR will rise from 700,000 deaths to 10 million deaths annually if nothing is done to halt the current trends [3]. Indeed, in 2019, only 8 years from when these projections were made, 1.27 million deaths were attributed to AMR, higher than those due to HIV, malaria, and tuberculosis [2].
JMIR Res Protoc 2024;13:e58116
Download Citation: END BibTex RIS

As a result, an efficient antimicrobial sealer is paramount for a successful root canal treatment [8,9].
In root canal obturation, a variety of sealers with similar properties have been used. Biocompatibility and a potent antimicrobial effect are the main criteria for developing a root canal sealer [10,11]. Conventional root canal sealers exhibit mild to strong antibacterial properties, but once set, the materials possess a diminished antimicrobial capacity [12,13].
JMIR Res Protoc 2024;13:e51351
Download Citation: END BibTex RIS

Antimicrobial resistance (AMR) is a serious public health threat [1]. It involves bacteria becoming resistant to antibiotics, potentially leading to infectious diseases no longer being treatable with antimicrobial agents and is driven by antibiotic use [2,3]. The patient, health care, and economic costs of AMR are significant.
JMIR Form Res 2024;8:e54458
Download Citation: END BibTex RIS

Inappropriate prescribing of antimicrobials and unwarranted variation in prescribing can contribute to increase of antimicrobial-resistant strains and patient adverse events in the short and long term [13].
We have previously shown that, in a prepandemic context, it is feasible to undertake point-of-care testing (POCT) for influenza in primary care in the England, with promising impacts on antimicrobial use and estimates of influenza vaccine effectiveness that are comparable with published data [14-16].
JMIR Res Protoc 2023;12:e46938
Download Citation: END BibTex RIS

Antimicrobial resistance (AMR) is recognized by the World Health Organization (WHO) as one of the most pressing concerns of our time. Overprescription and incorrect usage of antibiotics have further contributed to the worsening crisis. With deaths attributed to AMR reaching 4.95 million in 2019 [1] and a predicted cumulative global cost of $100 trillion by 2050, it is clear that novel strategies to combat AMR are desperately needed [2,3].
J Med Internet Res 2023;25:e42363
Download Citation: END BibTex RIS

The overuse and abuse of antibiotics have contributed to the global epidemic of antimicrobial resistance (AMR). Environmental contamination with antibiotic residues and resistant microorganisms and genes due to human activity has been demonstrated in pharmaceutical plants and may be a leading driver of the spread of ARB.
JMIR Res Protoc 2023;12:e39022
Download Citation: END BibTex RIS

The World Health Organization’s global action plan on antimicrobial resistance (AMR) recognizes that AMR “threatens the very core of modern medicine and the sustainability of an effective, global public health response to the enduring threat of infectious diseases” [1]. The contribution of antimicrobial use and overuse in intensifying selection pressures that lead to the emergence of AMR is well established [2].
JMIR Public Health Surveill 2023;9:e45121
Download Citation: END BibTex RIS

Antimicrobial resistance (AMR) occurs when microorganisms develop the ability to resist antimicrobial treatment designed to inhibit their growth and kill them. Bacteria, as the most extensively studied for AMR in both clinical and environmental settings, can exchange resistance genes between species in a microbial population [3]. Infected humans and animals can act as reservoirs and spread these resistant bacteria into the environment through various routes.
JMIR Res Protoc 2022;11(11):e37663
Download Citation: END BibTex RIS

Antimicrobial resistance (AMR) is associated with increased morbidity and mortality and is recognized as an emerging global health threat. If left unchecked, by 2050, AMR may contribute up to 10 million deaths per year [1]. In low- and middle-income countries (LMICs), particularly in Africa, data on drug-resistant infections are extremely scarce [2].
JMIR Public Health Surveill 2021;7(10):e29954
Download Citation: END BibTex RIS